Advertisement
Screener

Perrigo Company plc (PRGO) Long-Term Debt, Maturity, after Year Five

2.8 / 5 stars · 68/120 Roast Me

Perrigo Company plc Long-Term Debt, Maturity, after Year Five

Perrigo Company plc (PRGO) had Long-Term Debt, Maturity, after Year Five of $1.52 billion as of 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2026-02-26

  • 2025-12-31: Long-Term Debt, Maturity, after Year Five $1.52B.
  • 2024-12-31: Long-Term Debt, Maturity, after Year Five $2.22B.
  • 2023-12-31: Long-Term Debt, Maturity, after Year Five $2.46B.
  • 2022-12-31: Long-Term Debt, Maturity, after Year Five $2.19B.
Period endLong-Term Debt, Maturity, after Year Five
2025-12-31$1.52B
10-K · filed 2026-02-26
2024-12-31$2.22B
10-K · filed 2025-02-28
2023-12-31$2.46B
10-K · filed 2024-02-27
2022-12-31$2.19B
10-K · filed 2023-02-28
2021-12-31$1.15B
10-K · filed 2022-03-01
2020-12-31$1.85B
10-K · filed 2021-03-01
2019-12-31$1.10B
10-K · filed 2020-02-27
2018-12-31$1.79B
10-K · filed 2019-02-27
2017-12-31$2.17B
10-K · filed 2018-03-01
2016-12-31$3.14B
10-K · filed 2017-05-22
2015-12-31$2.95B
10-KT · filed 2016-02-25
2015-06-27$2.95B
10-K · filed 2015-08-13
2014-06-28$1.20B
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38